Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|July 12, 2017
The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensityPaolo Bossi, Maria Cossu Rocca, Renzo Corvò, et al.
Future Oncology (London, England)|August 8, 2018
Dabrafenib-trametinib combination in 'field-practice': an Italian experienceRoberta Depenni, Francesco De Rosa, Stefano Greco, et al.
Frontiers in Immunology|April 9, 2020
Single-Cell Approaches to Profile the Response to Immune Checkpoint InhibitorsLara Gibellini, Sara De Biasi, Camillo Porta, et al.
Surgical Oncology|July 24, 2025
Surgery versus immunotherapy in locally advanced cutaneous carcinoma of the external ear: A multicenter studyFrancesco Mattioli, Matteo Miglio, Margherita Basso, et al.
Internal and Emergency Medicine|December 25, 2014
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and womenFederica Domati, Gabriele Luppi, Luca Reggiani-Bonetti, et al.
Molecular and Clinical Oncology|December 10, 2019
Immunohistochemical mismatch repair proteins expression as a tool to predict the melanoma immunotherapy responseGiovanni Ponti, Giovanni Pellacani, Aldo Tomasi, et al.
Laryngoscope Investigative Otolaryngology|September 19, 2025
Other Than Complete Response in Oropharyngeal Carcinoma: Patient and Tumor-Related FactorsFrancesco Mattioli, Matteo Miglio, Edoardo Serafini, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 9, 2018
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patientsGiovanni Ponti, Monia Maccaferri, Marco Manfredini, et al.
Oral Diseases|October 14, 2020
Second primary tumors in head and neck cancer patients: The importance of a "tailored" surveillanceFederica Bertolini, Lucia Trudu, Federico Banchelli, et al.
Tumori|February 8, 2013
Survival in patients with newly diagnosed conventional glioblastoma: a modified prognostic score based on a single-institution seriesFederica Bertolini, Elena Zunarelli, Caterina Baraldi, et al.
Pageof 6